Skip to main content
CivicGate

S 3087
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Stop Pills That Kill Act

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

Introduced Oct 30, 2025

Latest action (Oct 30, 2025) Read twice and referred to the Committee on the Judiciary.

Referred to
Judiciary Committee
Policy area
Crime and Law Enforcement
Issues
Criminal Justice
Legislative subjects (5)
Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDrug trafficking and controlled substancesU.S. Sentencing Commission

Summary

The bill amends the Controlled Substances Act to address counterfeit fentanyl and methamphetamine substances, particularly those in pill form that are marketed under false brand names. It requires the Drug Enforcement Administration to develop an enforcement and prevention plan within 180 days, including strategies to investigate and seize these substances and to expand education and prevention efforts targeted at youth. The bill also requires annual reports to Congress detailing the number of counterfeit substances seized, charges filed, convictions obtained, and prevention measures being implemented.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
2 cosponsors

Actions (2)
  1. Oct 30, 2025 Read twice and referred to the Committee on the Judiciary. · senate
  2. Oct 30, 2025 Introduced in Senate

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

  • HR 8005 — Stop Pills That Kill Act (shares 5 subjects)
  • HR 5166 — Financial Services and General Government Appropriations Act, 2026 (shares 5 subjects)
  • S 1410 — Smarter Sentencing Act of 2014 (shares 5 subjects)
  • HR 9770 — Continuing Appropriations Act, 2027 (shares 4 subjects)
  • HR 1266 — Combating Illicit Xylazine Act (shares 4 subjects)
  • S 545 — Combating Illicit Xylazine Act (shares 4 subjects)
  • HR 7148 — Consolidated Appropriations Act, 2026 (shares 4 subjects)
  • HR 7006 — Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026 (shares 4 subjects)

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 8005 — Stop Pills That Kill Act · Introduced Jul 21, 2026 · Cong. 119 87%
  • S 165 — Stopping Overdoses of Fentanyl Analogues Act · Introduced Jan 21, 2025 · Cong. 119 75%
  • HRES 1234 — Supporting the mission and goals of National Fentanyl Awareness Day in 2026, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people. · Introduced Apr 29, 2026 · Cong. 119 71%
  • S 2635 — Ending the Fentanyl Crisis Act of 2018 · Introduced Apr 11, 2018 · Cong. 115 69%
  • HR 1064 — Stopping Overdoses of Fentanyl Analogues Act · Introduced Feb 6, 2025 · Cong. 119 69%
  • S 3134 — Combating Counterfeit Pharmaceuticals Act of 2025 · Introduced Nov 6, 2025 · Cong. 119 69%

Full text

IN THE SENATE OF THE UNITED STATES

October 30, 2025

Mr. Grassley (for himself and Ms. Hassan) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Stop Pills That Kill Act”.

SEC. 2. DEFINITION.

In this Act, the term “counterfeit fentanyl or methamphetamine substance” means a substance that—

(1) contains fentanyl, any analogue of fentanyl, or methamphetamine; and

(2) is marketed, sold, or falsely bears the trademark, trade name, or other identifying mark, imprint, number, or any likeness thereof of another product.

SEC. 3. PROHIBITED ACTS.

Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting “, fentanyl, an analogue of fentanyl, or a counterfeit substance” after “methamphetamine”.

SEC. 4. COMPREHENSIVE PLAN.

Not later than 180 days after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration shall establish and implement an operation and response plan to address counterfeit fentanyl or methamphetamine substances that includes—

(1) strategies to enable and empower Federal law enforcement efforts to investigate and seize counterfeit fentanyl or methamphetamine substances;

(2) specific ways that education and prevention efforts to stop the use of counterfeit fentanyl or methamphetamine substances will be increased, including how—

(A) ongoing efforts, such as Operation Engage, are effective in increasing education and prevention; and

(B) how the efforts described in subparagraph (A) are tailored to youth and teen access; and

(3) an audit of current campaigns, including the “One Pill Can Kill” campaign, on counterfeit fentanyl or methamphetamine substances, including a review of data and other available information on how the campaigns can be tailored, adjusted, or improved to better address the flow of counterfeit fentanyl or methamphetamine substances.

SEC. 5. REPORT TO CONGRESS.

(a) Report.—Not later than 1 year after the date of enactment of this Act, and every year thereafter, the Attorney General, in consultation with the Administrator of the Drug Enforcement Administration and Director of the Office of National Drug Control Policy, shall submit to Congress a report on information regarding the collection and prosecutions of counterfeit fentanyl or methamphetamine substances.

(b) Contents.—The report required under subsection (a) shall include the following:

(1) Data on the aggregate number of counterfeit fentanyl or methamphetamine substances seized and collected by Federal law enforcement agencies.

(2) A breakdown on how many counterfeit fentanyl or methamphetamine substances are in pill form.

(3) A breakdown on which illicit substances are present in the counterfeit fentanyl or methamphetamine substances that are in pill form.

(4) Data outlining where and when counterfeit fentanyl or methamphetamine substances were seized.

(5) Data on the charges filed against those manufacturing, distributing or dispensing, or possessing with the intent to distribute or dispense, a counterfeit fentanyl or methamphetamine substance, particularly in pill form, pursuant to paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)), unless disclosure of the data would—

(A) require unsealing an indictment; or

(B) undermine investigations and charges brought by the Department of Justice.

(6) Data on the convictions and sentences against those who are found guilty under paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) as it pertains to counterfeit fentanyl or methamphetamine substances, particularly those in pill form.

(7) Any prevention measures that the Department of Justice, Drug Enforcement Administration, or Office of National Drug Control Policy are undertaking to limit and reduce the spread of counterfeit fentanyl or methamphetamine substances in pill form, including ongoing public awareness campaigns. <all>

Comments

Comments

Loading comments…